UNSPSC 51172135: Heptaverine

This classification denotes an antispasmotic agent with the molecular formula C18H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0035H8M4YL, chemically known as n,n-dimethyl-n-(3-(8,9,10-trinorbornan-2-yliden)-3-phenylpropyl)amin but generally known as heptaverine, which bears US NIH Compound Identifier 3038460. European Medicines Agency schedules Heptaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08017MIG.

UNSPSC 51172135 Heptaverine is a Commodity code that does not see meaningful activity under recent state and local procurement opportunities. The three most recent opportunities tagged under this code involve offender drug testing services (Collin County, Texas), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations actually procure heptaverine or reference the substance; the code assignment appears to be a tagging error rather than a reflection of what state and local governments are actually buying under it.

No recent state and local opportunities specifically solicit heptaverine as a commodity or as part of a pharmaceutical procurement scope. Until the source reflects active, heptaverine-focused purchasing activity by state departments, counties, municipalities, school districts, or other local bodies, this code presents minimal business development opportunity.